Provided by Tiger Trade Technology Pte. Ltd.

Kura Oncology

10.67
+0.14001.33%
Post-market: 10.670.00000.00%16:15 EDT
Volume:1.10M
Turnover:11.76M
Market Cap:947.22M
PE:-3.17
High:10.99
Open:10.43
Low:10.32
Close:10.53
52wk High:13.90
52wk Low:7.36
Shares:88.77M
Float Shares:70.60M
Volume Ratio:0.62
T/O Rate:1.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3668
EPS(LYR):-3.1784
ROE:-167.71%
ROA:-31.30%
PB:19.56
PE(LYR):-3.36

Loading ...

Is Kura Oncology's (KURA) Zacks Upgrade Quietly Reframing Its Precision Oncology Risk‑Reward Story?

Simply Wall St.
·
Sep 02

Kura Oncology to Participate in Three Investor Conferences in September

GlobeNewswire
·
Sep 01

Kura Oncology (KURA) Receives a Buy from Mizuho Securities

TIPRANKS
·
Aug 31

Kura Oncology Shares Rise After CEO Purchases 100,000 Shares

MT Newswires Live
·
Aug 26

Kura Oncology CEO buys $1.24M in common stock

TIPRANKS
·
Aug 25

Kura Oncology CEO Troy Wilson Acquires 100,000 Common Shares Valued at $1,239,000

Reuters
·
Aug 25

Kura Oncology Chief Commercial Officer Brian T. Powl Sells 4,345 Common Shares for USD 51,656.85

Reuters
·
Aug 25

Kura Oncology Price Target Maintained with a $24.00/Share by Citizens

Dow Jones
·
Aug 24

UBS Remains a Buy on Kura Oncology (KURA)

TIPRANKS
·
Aug 21

Kura Oncology Currently up Nine Days Straight, on Track for Record Winning Streak

Dow Jones
·
Aug 18

Kura Oncology CEO buys $1.11M in common stock

TIPRANKS
·
Aug 18

Kura Oncology CEO Troy Wilson Reports Purchase of 100,000 Common Shares Worth $1.11 Million

Reuters
·
Aug 18

Celcuity Posts Narrower-than-Expected Loss as R&D Costs Decreased

Reuters
·
Aug 14

Kura Jumps on Narrower-than-Expected Quarterly Loss

Reuters
·
Aug 13

Phil Nadeau Reiterates Buy on Kura Oncology as Komzifti Outperforms Expectations and Pipeline Progress Strengthens Long-Term Outlook

TIPRANKS
·
Aug 13

Kura Oncology Price Target Raised to $38.00/Share from $36.00 by Wedbush

Dow Jones
·
Aug 13

Karyopharm Q2 Revenue Falls as License Revenue Drops; Expects Funds to Last into September

Reuters
·
Aug 13

Wedbush Adjusts Price Target on Kura Oncology to $38 From $36, Keeps Outperform Rating

MT Newswires Live
·
Aug 13

Barclays Reaffirms Their Buy Rating on Kura Oncology (KURA)

TIPRANKS
·
Aug 13

Sweden's RaySearch Q2 Order Intake Rises on Clinical Adoption

Reuters
·
Aug 13